“Winning this award is a testament to our efforts in using AI to improve chronic disease management,” Dr. Xie said. “By ...

SHANGHAI, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, was recognized as an “Outstanding Growth Story ...

EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future. The two companies continue to grow their wearables lineup ...

Photo: Esteworld Representative Office - Covent Garden, London ...

(“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer-packaged goods company, announced that its premium ...

The DEXA-L, part of the DEXA Technology Platform, is a stand-alone device for anterior lumbar interbody fusion (ALIF) procedures and is the first of its kind in the world. It is the first spinal ...

After these repurchases, 1,885,913 shares of Series B Preferred remain outstanding. About Regional Health Properties, Inc.

The U.S. Food and Drug Administration (FDA) approved ZURZUVAE in August 2023 and the Drug Enforcement Agency (DEA) scheduled it as a Class IV controlled substance in October 2023. In August 2025, ...

Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the closing of its previously announced public offering of an aggregate of 5,000,000 shares of the Company’s common ...

REDWOOD CITY, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by ...

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its ...

Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrant. Additional cost optimization measures expected to realize total ...